
Opdivo (nivolumab) showed the biggest increase in survival for patients with head and neck cancer for 20 years, according to …

Gilead’s dominance of the hepatitis C market is under severe threat after a federal jury ruled in favour of MSD …

From Humira to Cubicin, some multi-billion dollar drugs are set to be hit hard by patent expiries next year, and …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

